Company: LGN
Filing Date: 2025-08-15
Form Type: S-1
Source: 0001193125-25-181698
Chunk: 206

Company: Legence Corp.
Filing Date: 2025-08-15
Form: S-1
Chunk 206
---
 split, share combination, share dividend, exchange of shares or other recapitalization, merger or otherwise, that results in an increase or decrease in the number of outstanding shares of Common Stock,
appropriate adjustments will be made by the Committee in the shares subject to an award under the 2025 Plan. The Committee will also have the discretion to make certain adjustments to awards in the event of a change in control, such as accelerating
the vesting or exercisability of awards, requiring the surrender of an award, with or without consideration, or making any other adjustment or modification to the award that the Committee determines is appropriate in light of such transaction.

Clawback

All awards
granted under the 2025 Plan will be subject to clawback, cancellation, recoupment, rescission, payback, reduction, or other similar action in accordance with any Company clawback or similar policy or any applicable law related to such actions.

Amendment and Termination

Our board of directors or the Committee may amend or terminate the 2025 Plan at any time; however, stockholder approval will be required for
any amendment to the extent necessary to comply with applicable law. Stockholder approval will be required to make amendments that (i) increase the aggregate number of shares that may be issued under the 2025 Plan or (ii) change the
classification of individuals eligible to receive awards under the 2025 Plan. The 2025 Plan will remain in effect for a period of 10 years (unless earlier terminated by our board of directors).

148

IPO Grants

In connection with this offering, we expect to grant restricted stock units and stock
options under the 2025 Plan to certain employees (collectively, the “IPO Grants”), including our named executive officers, assuming an initial public offering price of $ per share, the midpoint of the
estimated price range set forth on the cover page of this prospectus, with the actual number of restricted stock units and stock options to be determined at the pricing of this offering. Each stock option granted as of the pricing of this offering
will have an exercise price equal to the initial public offering price in this offering. As of the date of this prospectus, the individual award values for each named executive officer are not yet known. Each IPO Grant to our named executive
officers will consist of 50% of restricted stock units and 50% stock options, both of which will vest in three substantially equal installments on each of the first, second and third annivers